Oh, Canada: Exopharm acquire Tryp Therapeutics
In a move known as a reverse merger, Exopharm Ltd have acquired Canadian biotech company Tryp Therapeutics, who will occupy Exopharm’s place on the ASX.
In a move known as a reverse merger, Exopharm Ltd have acquired Canadian biotech company Tryp Therapeutics, who will occupy Exopharm’s place on the ASX.
In this article… The disruption of hormone regulatory pathways within the human body can have dramatic and rippling impacts on an individual’s homeostatic balance impacting their reproductive health. The Endocrine System is an Important Regulator of Homeostasis When you hear the term reproductive biotechnology, you may instantly think of assisted reproductive technologies (ARTs) such as …
Read more “Why You Need To Understand Hormones and Homeostasis”
Overpopulation is an issue of the past, or soon it will be. Within the scientific community, it has become increasingly apparent that the human population is reaching a point of exponential decline. This might seem dramatic, however, analysing the total fertility rate in Australia can help us to understand. The total fertility rate or birth …
Read more “Reproductive Biotechnology, The Saviour of the Human Race”
In this article.. The biotechnology industry is constantly evolving, with new companies emerging and established players making advancements every day. As we move through 2024, It’s important to recognise which companies are poised to make a significant impact. Currently, the market is leaning optimistically due to the high number of acquisitions into bopharma companies performed …
In this article: Introduction The drug development pipeline (DDP) is, at its core, the fundamental process that biopharma companies undergo in the quest to bring their therapeutic to market. It is composed of multiple stages that can be lumped into two groups: research and development. The research stages include everything from discovery of a potential …